Cystic Fibrosis. II. The Urinary Mucociliary Inhibitor

Publisher Website
Google Scholar
Abstract
The cystic fibrosis cationic mucociliary inhibitor was purified from [human] urine by ion exchange chromatography, gel filtration, lectin affinity chromatography, isoelectric focusing and high performance liquid chromatography. The molecular size of the cationic mucociliary inhibitor was estimated to be in the range of 4000-13,500 MW, by its elution on Sephadex G-50 and between 7500 and 12,750 MW, by urea-sodium dodecyl sulfate polyacrylamide gel electrophoresis. In addition to the cationic mucociliary inhibitor, an anionic mucociliary inhibitor was also detected in the urinary fraction isoelectrically focused between pH 4.5-4.9. The identity of the mucociliary inhibitor as a glycoprotein was established in the current study by affinity chromatography on Phaseolus lunatus lectin, by radiolabeling the carbohydrate with galactose oxidase and tritiated sodium borohydride, and by determining the presence of a large concentration of glucosamine and small amounts of galactosamine by amino acid analysis. The amino acid analysis of the purified major component of the cationic mucociliary inhibitor reveals that the glucosamine concentration represents a high percentage of the composition of the glycoprotein.